My understanding is that trials for other tumors would be financed with funds obtained from MDS partnering. That has likely been Faron’s strategy – or at least one of them.
2 Likes
My understanding is that trials for other tumors would be financed with funds obtained from MDS partnering. That has likely been Faron’s strategy – or at least one of them.